Pressio Spine Appoints Dr. Kent Ellington as CEO to Drive Commercial Scale-Up

Pressio Spine has named Co-Founder Dr. Kent Ellington as Chief Executive Officer, effective immediately. Following a highly productive tenure as Chairman, during which the company's R&D and IP portfolio outpaced the prior three years of progress, Dr. Ellington will now lead the commercialization of the CONTINUUM™ platform. His transition to CEO marks a strategic shift toward establishing a nationwide distributor network and activating primary ASC accounts.